Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection

References

• Butler CR, Wightman A, Richards CA, et al. Thematic analysis of the health records of a national sample of us veterans with advanced kidney disease evaluated for transplant. JAMA Intern Med. 2021;181:212–219. doi:10.1001/jamainternmed.2020.6388
   PubMed Web of Science ®Google Scholar
• Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351:2715–2729. doi:10.1056/NEJMra033540
   PubMed Web of Science ®Google Scholar
• de Leur K, Clahsen-van groningen MC, van den Bosch TPP, et al. Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection. Clin Exp Immunol. 2018;192:224–232. doi:10.1111/cei.13099
   PubMed Web of Science ®Google Scholar
• Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013;369:1215–1226. doi:10.1056/NEJMoa1302506
   PubMed Web of Science ®Google Scholar
• Loupy A, Lefaucheur C. Antibody-mediated rejection of solid-organ allografts. N Engl J Med. 2018;379:1150–1160. doi:10.1056/NEJMra1802677
   PubMed Web of Science ®Google Scholar
• Budde K, Durr M. Any progress in the treatment of antibody-mediated rejection? J Am Soc Nephrol. 2018;29:350–352. doi:10.1681/ASN.2017121296
   PubMed Web of Science ®Google Scholar
• Shanahan F, Ghosh TS, O’Toole PW. The healthy microbiome-what is the definition of a healthy gut microbiome? Gastroenterology. 2021;160:483–494. doi:10.1053/j.gastro.2020.09.057
   PubMed Web of Science ®Google Scholar
• Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474:1823–1836. doi:10.1042/BCJ20160510
   PubMed Web of Science ®Google Scholar
• Agus A, Clement K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70:1174–1182. doi:10.1136/gutjnl-2020-323071
   PubMed Web of Science ®Google Scholar
• Cani PD. Gut microbiota - at the intersection of everything? Nat Rev Gastroenterol Hepatol. 2017;14:321–322. doi:10.1038/nrgastro.2017.54
   PubMed Web of Science ®Google Scholar
• Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369–2379. doi:10.1056/NEJMra1600266
   PubMed Web of Science ®Google Scholar
• Cussotto S, Sandhu KV, Dinan TG, Cryan JF. The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective. Front Neuroendocrinol. 2018;51:80–101. doi:10.1016/j.yfrne.2018.04.002
   PubMed Web of Science ®Google Scholar
• Wang X, Yang S, Li S, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69:2131–2142. doi:10.1136/gutjnl-2019-319766
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282–1286. doi:10.1038/nature08530
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H, Howard AG, et al. Circulating Short-Chain fatty acids are positively associated with adiposity measures in Chinese adults. Nutrients. 2020;12. doi:10.3390/nu12072127
   Web of Science ®Google Scholar
• Acharya MR, Sparreboom A, Venitz J, Figg WD. Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol. 2005;68:917–932. doi:10.1124/mol.105.014167
   PubMed Web of Science ®Google Scholar
• Kendrick SF, O’Boyle G, Mann J, et al. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology. 2010;51:1988–1997. doi:10.1002/hep.23572
   PubMed Web of Science ®Google Scholar
• Usami M, Kishimoto K, Ohata A, et al. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res. 2008;28:321–328. doi:10.1016/j.nutres.2008.02.012
   PubMed Web of Science ®Google Scholar
• Wu H, Singer J, Kwan TK, et al. Gut microbial metabolites induce donor-specific tolerance of kidney allografts through induction of T regulatory cells by short-chain fatty acids. J Am Soc Nephrol. 2020;31:1445–1461. doi:10.1681/ASN.2019080852
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Wu X, et al. Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation. Appl Microbiol Biotechnol. 2021;105:2473–2484. doi:10.1007/s00253-020-11069-x
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262–1267. doi:10.1126/science.1223813
   PubMed Web of Science ®Google Scholar
• Loupy A, Haas M, Roufosse C, et al. The banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant. 2020;20:2318–2331. doi:10.1111/ajt.15898
   PubMed Web of Science ®Google Scholar
• Triba MN, Le Moyec L, Amathieu R, et al. PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. Mol Biosyst. 2015;11(1):13–19. doi:10.1039/c4mb00414k
   PubMedGoogle Scholar
• Piotti G, Gandolfini I, Palmisano A, Maggiore U. Metabolic risk profile in kidney transplant candidates and recipients. Nephrol Dial Transplant. 2019;34:388–400. doi:10.1093/ndt/gfy151
   PubMed Web of Science ®Google Scholar
• Liu X, Zheng H, Lu R, et al. Intervening effects of total alkaloids of corydalis saxicola bunting on rats with antibiotic-induced gut microbiota dysbiosis based on 16S rRNA gene sequencing and untargeted metabolomics analyses. Front Microbiol. 2019;10:1151. doi:10.3389/fmicb.2019.01151
   PubMed Web of Science ®Google Scholar
• Gao K, Pi Y, Peng Y, Mu CL, Zhu WY. Time-course responses of ileal and fecal microbiota and metabolite profiles to antibiotics in cannulated pigs. Appl Microbiol Biotechnol. 2018;102:2289–2299. doi:10.1007/s00253-018-8774-2
   PubMed Web of Science ®Google Scholar
• Jiao W, Zhang Z, Xu Y, et al. Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota. Am J Transplant. 2020;20:2413–2424. doi:10.1111/ajt.15880
   PubMed Web of Science ®Google Scholar
• Wang Z, Cui B, Zhang F, et al. Development of a correlative strategy to discover colorectal tumor tissue derived metabolite biomarkers in plasma using untargeted metabolomics. Anal Chem. 2019;91:2401–2408. doi:10.1021/acs.analchem.8b05177
   PubMed Web of Science ®Google Scholar
• Liu F, Liu J, Wang TTY, et al. Molecular and microbial signatures predictive of prebiotic action of neoagarotetraose in a dextran sulfate sodium-induced murine colitis model. Microorganisms. 2020;8:995. doi:10.3390/microorganisms8070995
   PubMed Web of Science ®Google Scholar
• Zhu S, Liu S, Li H, et al. Identification of gut microbiota and metabolites signature in patients with irritable bowel syndrome. Front Cell Infect Microbiol. 2019;9:346. doi:10.3389/fcimb.2019.00346
   PubMed Web of Science ®Google Scholar
• Singh Y, Trautwein C, Dhariwal A, et al. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Sci Rep. 2020;10:16131. doi:10.1038/s41598-020-72903-w
   PubMed Web of Science ®Google Scholar
• Marzocco S, Di Paola R, Serraino I, et al. Effect of methylguanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol. 2004;484:341–350. doi:10.1016/j.ejphar.2003.11.011
   PubMed Web of Science ®Google Scholar
• Marzocco S, Di Paola R, Ribecco MT, et al. Effect of methylguanidine in a model of septic shock induced by LPS. Free Radic Res. 2004;38:1143–1153. doi:10.1080/10715760410001725517
   PubMed Web of Science ®Google Scholar
• Deen CPJ, Veen AV, Gomes-Neto AW, et al. Urinary Excretion of N(1)-Methylnicotinamide and N(1)-Methyl-2-Pyridone-5-carboxamide and mortality in kidney transplant recipients. Nutrients. 2020;12:2059. doi:10.3390/nu12072059
   PubMed Web of Science ®Google Scholar
• Urso A, Leiva-Juarez MM, Briganti DF, et al. Aspiration of conjugated bile acids predicts adverse lung transplant outcomes and correlates with airway lipid and cytokine dysregulation. J Heart Lung Transplant. 2021;40:998–1008. doi:10.1016/j.healun.2021.05.007
   PubMed Web of Science ®Google Scholar
• Zhang CYK, Ahmed M, Huszti E, et al. C.-. investigators, Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration. J Heart Lung Transplant. 2020;39:934–944. doi:10.1016/j.healun.2020.05.006
   PubMed Web of Science ®Google Scholar
• Girlanda R, Cheema AK, Kaur P, et al. Metabolomics of human intestinal transplant rejection. Am J Transplant. 2012;12:S18–26. doi:10.1111/j.1600-6143.2012.04183.x
   PubMed Web of Science ®Google Scholar
• Lin F, Ou Y, Huang CZ, Lin SZ, Ye YB. Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats. Sci Rep. 2017;7:15422. doi:10.1038/s41598-017-15761-3
   PubMed Web of Science ®Google Scholar
• Lee CF, Lo YC, Cheng CH, et al. Preventing allograft rejection by targeting immune metabolism. Cell Rep. 2015;13:760–770. doi:10.1016/j.celrep.2015.09.036
   PubMed Web of Science ®Google Scholar